Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: Final results of a phase 2, single-blind, randomised controlled trial (COV006).
Li G, Marchevsky NG, Macaulay G, Aley P, Baughan H, Plested E, Bibi S, Cappuccini F, Faust SN, Heath PT, Muller J, Robinson H, Roderick M, Snape M, Smith D, Song R, Liu X, Lambe T, Pollard AJ; COV006 trial team. Li G, et al. Among authors: plested e. Vaccine. 2025 Aug 30;62:127597. doi: 10.1016/j.vaccine.2025.127597. Epub 2025 Aug 25. Vaccine. 2025. PMID: 40857840 Free article. Clinical Trial.
Understanding the interaction of upper respiratory tract infection with respiratory syncytial virus and Streptococcus pneumoniae using a human challenge model: a multicenter, randomized controlled study protocol.
Brito-Mutunayagam S, Hamilton DO, Mitsi E, Solórzano C, Li G, Rocha De Macedo B, Elterish F, Liu X, Tanha K, White R, Hyder-Wright A, Patel B, Urban BC, Whelan C, Trari Belhadef H, Robinson H, Plested E, Thompson A, Lahuerta M, Kanevsky I, Swanson K, Aliabadi N, Catusse J, Theilacker C, Gessner BD, Mazur NI, Chiu C, Collins AM, Morton B, Ramasamy MN, Ferreira DM. Brito-Mutunayagam S, et al. Among authors: plested e. PLoS One. 2025 Jul 1;20(7):e0325149. doi: 10.1371/journal.pone.0325149. eCollection 2025. PLoS One. 2025. PMID: 40591700 Free PMC article.
A phase 1/2a clinical trial to assess safety and immunogenicity of an adenoviral-vectored capsular group B meningococcal vaccine.
Dold C, Oguti B, Silva-Reyes L, Stanzelova A, Raymond M, Smith CC, Moore M, Barton A, Choi EM, Plested E, Tanha K, Louth J, Holland A, Cook R, King J, Lucidarme J, Borrow R, Hill AVS, Beernink PT, Liu X, Pollard AJ, Rollier CS. Dold C, et al. Among authors: plested e. Sci Transl Med. 2025 May 7;17(797):eadn1441. doi: 10.1126/scitranslmed.adn1441. Epub 2025 May 7. Sci Transl Med. 2025. PMID: 40333993 Clinical Trial.
Safety and humoral immunogenicity of the ChAdOx1 nCoV-19 vaccine administered as a fourth dose booster following two doses of ChAdOx1 nCoV-19 and a third dose of BNT162b2 (COV009): A prospective cohort study.
Feng S, Bibi S, Aley PK, Cappuccini F, Clutterbuck EA, Conlin K, Ebrahimi N, Eordogh A, Faust SN, Felle S, Green J, Gill H, Mujadidi Y, Oladunjoye I, Owino N, Plested E, Robinson H, Stuart A, Voysey M, Pollard AJ, Lambe T. Feng S, et al. Among authors: plested e. J Infect. 2025 Feb;90(2):106423. doi: 10.1016/j.jinf.2025.106423. Epub 2025 Jan 16. J Infect. 2025. PMID: 39826861 Free article.
Pneumococcal Carriage and Disease in Adults in England, 2011-2019: The Importance of Adults as a Reservoir for Pneumococcus in Communities.
El Safadi D, Hitchins L, Howard A, Aley P, Bowman J, Bertran M, Collins A, Colin-Jones R, Elterish F, Fry NK, Gordon SS, Gould K, Hinds J, Horn E, Hyder-Wright A, Kandasamy R, Ladhani S, Litt D, Mitsi E, Murphy A, Pollard AJ, Plested E, Pojar S, Ratcliffe H, Robertson MC, Robinson H, Snape MD, Solórzano C, Voysey M, Begier E, Catusse J, Lahuerta M, Theilacker C, Gessner BD, Tiley KS, Ferreira DM. El Safadi D, et al. Among authors: plested e. J Infect Dis. 2025 Feb 4;231(1):e17-e27. doi: 10.1093/infdis/jiae351. J Infect Dis. 2025. PMID: 39013016 Free PMC article.
The Impact of Infant Bacille Calmette-Guérin Vaccination on the Immunogenicity of Other Vaccines: A Randomized Exploratory Study.
Maytum A, Porter D, de Whalley P, Thompson A, Plested E, Kerridge S, Liu X, Smits G, van der Klis F, Snape MD, Clutterbuck E, Pollard AJ. Maytum A, et al. Among authors: plested e. Pediatr Infect Dis J. 2024 Aug 1;43(8):809-812. doi: 10.1097/INF.0000000000004373. Epub 2024 May 8. Pediatr Infect Dis J. 2024. PMID: 38717982 Clinical Trial.
Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents.
Ratcliffe H, Tiley KS, Longet S, Tonry C, Roarty C, Watson C, Amirthalingam G, Vichos I, Morey E, Douglas NL, Marinou S, Plested E, Aley PK, Galiza E, Faust SN, Hughes S, Murray C, Roderick MR, Shackley F, Oddie S, Lee TWR, Turner DPJ, Raman M, Owens S, Turner PJ, Cockerill H, Lopez Bernal J, Ijaz S, Poh J, Shute J, Linley E, Borrow R, Hoschler K, Brown KE, Carroll MW, Klenerman P, Dunachie SJ, Ramsay M, Voysey M, Waterfield T, Snape MD. Ratcliffe H, et al. Among authors: plested e. iScience. 2023 Nov 21;26(12):108500. doi: 10.1016/j.isci.2023.108500. eCollection 2023 Dec 15. iScience. 2023. PMID: 38089581 Free PMC article.
Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3): A randomised controlled trial.
Kelly E, Greenland M, de Whalley PCS, Aley PK, Plested EL, Singh N, Koleva S, Tonner S, Macaulay GC, Read RC, Ramsay M, Cameron JC, Turner DPJ, Heath PT, Bernatoniene J, Connor P, Cathie K, Faust SN, Banerjee I, Cantrell L, Mujadidi YF, Belhadef HT, Clutterbuck EA, Anslow R, Valliji Z, James T, Hallis B, Otter AD, Lambe T, Nguyen-Van-Tam JS, Minassian AM, Liu X, Snape MD; Com-COV3 Study Group. Kelly E, et al. Among authors: plested el. J Infect. 2023 Sep;87(3):230-241. doi: 10.1016/j.jinf.2023.06.007. Epub 2023 Jun 17. J Infect. 2023. PMID: 37331429 Free PMC article. Clinical Trial.
Pneumococcal carriage following PCV13 delivered as one primary and one booster dose (1 + 1) compared to two primary doses and a booster (2 + 1) in UK infants.
Goldblatt D, Andrews NJ, Sheppard CL, Rose S, Aley PK, Roalfe L, Southern J, Robinson H, Pearce E, Plested E, Johnson M, Litt DJ, Fry NK, Waight P, Snape MD, Miller E. Goldblatt D, et al. Among authors: plested e. Vaccine. 2023 May 5;41(19):3019-3023. doi: 10.1016/j.vaccine.2023.04.017. Epub 2023 Apr 10. Vaccine. 2023. PMID: 37045683 Free article. Clinical Trial.
49 results